Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for AKT
Most Correlated Studies
- T helper D10 cells time course TCR activation in the presence of Akt inhibition
- CD8-positive melanoma-infiltrating lymphocytes treated with AKT inhibitor VIII (AKTi-1-2)
- Breast adenocarcinoma MCF7 and colon carcinoma HCT116 cells treated w/ small molecule AKT inhibitor
- PDK1 null and Akt inhibitor treated cytotoxic T-lymphocyte expression data
- Akt transfected regulatory T cells treated with TGFbeta
Most Relevant Literature
- Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
- Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression.
- Osthole Protects Bone Marrow-Derived Neural Stem Cells from Oxidative Damage through PI3K/Akt-1 Path…
- Akt1 and akt3 exert opposing roles in the regulation of vascular tumor growth.
- PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling.
Most Relevant Clinical Trials
- Autonomic Phenotype Before and After Akt Inhibition
- Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
- Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Ca…
- Safety, Pharmacokinetics (PK) of AKT and MEK Combination
- Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
